The Respiratory Effectiveness Group is an investigator-led, not-for-profit research initiative that has been set up in recognition of the potential value of real-life research and the need to harness real-life evidence to inform meaningful practice guidelines, drug licensing and prescribing decisions.
| Website | http://www.effectivenessevaluation.org/about-us/ |
| Employees | 7 (3 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Research |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Chiesi Group, Mylan Belgium +36 more (view full list) |
Looking for a particular Respiratory Effectiveness Group employee's phone or email?
Respiratory Effectiveness Group Questions
Adam Marsh is the CEO of Respiratory Effectiveness Group.
3 people are employed at Respiratory Effectiveness Group.
Top Respiratory Effectiveness Group Employees
-
Adam Marsh
Chief Executive Officer at Respiratory Effectiveness Group
England, United Kingdom1 -
Gina Amanda
IPF and ILD Working Group at Respiratory Effectiveness Group
Jakarta, Indonesia1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
